Latest News
Amneal Pharmaceuticals, Inc.
- Amneal Pharma Opens Rs 135 Crore Ahmedabad Office To Strengthen Global Operations
- Amneal Pharmaceuticals inaugurates Rs 135 crore office in Ahmedabad
- Amneal Pharmaceuticals injects Rs 135 Cr to open new office in Ahmedabad
- Amneal Pharmaceuticals opens $15 million office in Ahmedabad
- Amneal Opens New Office in Ahmedabad, Supporting Collaboration and Global Operations
- Genentech, Novartis Say Amneal Infringed Allergy Drug Patents
- Amneal to report Q3 2026 earnings on Nov 3 with a live webcast.
- Amneal to Report Third Quarter 2026 Results on November 3, 2026
- Macleods, Amneal Recall Olanzapine, Exenatide Products in US Over Quality Issues
- UBS reiterates Amneal Pharmaceuticals stock Buy rating on HRT growth By Investing.com
- Amneal, Macleods Pharma recall drugs in US
- Amneal wins FDA approval for lanreotide, targets $983 million US market
Headlines from the last 30 days, linking to the original publishers. See all market news →